Affordable Health Care
The cost of healthcare in the Netherlands and elsewhere is rising. Oncode is mindful of the need for new innovations in cancer therapy to reach patients at an affordable price. For this reason, Oncode focuses a substantial part of its strategy on the affordability of new medical solutions.
The Oncode approach
In order to reach these affordable healthcare goals, we set up several activities.
- One of the ways that Oncode is planning for sustainable implementation of research outputs from the very beginning, is through implementation of the Socially Responsible Licensing principlesestablished by the Netherlands Federation of University Medical Centres (NFU). Oncode participated in the relevant NFU working group and was one of the first institutes to formally endorse these principles. We are currently implementing them to make sure that new scientific insights are translated into novel therapies for patients in a responsible way.
- Oncode will ensure that 20% of its clinical activities within the Oncode Clinical Proof of Concept Programme (CPoC) will be focused on either personalized medicine (patient stratification) or drug repurposing. In partnership with the Netherlands Organisation for Health Research and Development (ZonMW), Oncode will award several CPoC projects dedicated to affordable healthcare research. One project has already been awarded, two additional affordable healthcare clinical projects are currently under evaluation.
- Drug repurposing is an effective approach to rapidly identify novel indications for known drugs and compounds. In order to support researchers in bringing novel therapeutic applications to the patient at affordable costs, Oncode has initiated the Drug Repurposing Programme. The goal of this programme is to stimulate research that re-purposes abandoned, off-patent, or patent expiring drugs.